CD8A and colitis: In sulfasalazine-treated ERAP1+/− colitis mice, the percentages of NK1.1+ (p < 0.05) and CD8+NK1.1+ (p < 0.05) cells were reduced than those in ERAP1+/− healthy controls (Figures 4G, H).